BDR Pharmaceuticals - About the company
BDR Pharmaceuticals is a late stage company based in Mumbai (India), founded in 2003. It operates as a Developer and manufacturer of APIs as well as finished products. BDR Pharmaceuticals has raised $94.9M in funding from Multiples Alternate Asset Management, with a current valuation of ₹*****. The company has 347 active competitors, including 22 funded and 88 that have exited. Its top competitors include companies like Bayer, Biological E and Wockhardt.
Company Details
BDR Pharmaceuticals develops and manufactures API. The company also offer new delivery systems and development of new generics. The products are of various therapeutic categories including oncology, critical care, gynecology, respiratory, antidiabetics, neurology, and others. The company has manufacturing facilities certified by WHO-GMP.
- Website
- www.bdrpharma.com/
- Phone Number
- +91 **********
- Registered Address
- R S NO 578, 579/A, VILLAGE LUNA, ECP ROAD, TALUKA- PADRA, Padra, Vadodara, Vadodara, Gujarat, India, 391440
Key Metrics
Founded Year
2003
Location
Mumbai, India
Stage
Late Stage
Total Funding
$94.9M in 1 round
Latest Funding Round
Post Money Valuation
₹***** as on Sep 15, 2023
Investors
Ranked
38th among 347 active competitors
Annual Revenue
₹1,000+ Cr as on Mar 31, 2025
Employee Count
1,006 as on Sep 30, 2026
Similar Companies
Legal entities associated with BDR Pharmaceuticals
BDR Pharmaceuticals is associated with 5 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
BD-VERSE LLP CIN: ABA-8199 , India, Active | Feb 24, 2022 | 0 - ₹10 Cr (As on Mar 31, 2025) | - | |
MAGNUM CHEMI-GRAN PRIVATE LIMITED CIN: U24230TG2005PTC046533 , India, Active | Jun 14, 2005 | ₹10 - ₹50 Cr (As on Mar 31, 2025) | 52 (As on Feb 28, 2025) | |
VIRDEV INTERMEDIATES PRIVATE LIMITED CIN: U24230GJ1994PTC021189 , India, Active | Feb 01, 1994 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 350 (As on Jan 31, 2025) | |
BDR LIFESCIENCES PRIVATE LIMITED CIN: U24230GJ1993PTC020258 , India, Active | Sep 24, 1993 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 302 (As on Feb 28, 2025) | |
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED CIN: U24230MH2002PTC137329 , India, Active | Sep 24, 2002 | ₹1,000+ Cr (As on Mar 31, 2025) | 1668 (As on May 01, 2026) |
Sign up to download BDR Pharmaceuticals' company profile
BDR Pharmaceuticals's funding and investors
BDR Pharmaceuticals has raised a total funding of $94.9M over 1 round. Its latest funding round was a PE round on Jan 24, 2022 for $*****. 10 investors participated in its latest round. BDR Pharmaceuticals has 11 institutional investors and 5 angel investors.
Here is the list of recent funding rounds of BDR Pharmaceuticals:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 24, 2022 | 7160509 | PE | 9377975 | 7549349 | 4862749 | 6286876 |
View details of BDR Pharmaceuticals's funding rounds and investors
BDR Pharmaceuticals' founders and board of directors
Founder? Claim ProfileBDR Pharmaceuticals' Board of Directors
BDR Pharmaceuticals's board has 5 active members. Raheel Shah, Jayesh Shantilal Shah, Dheer Shah and Tejash Shah are part of team and Aravind Manappa Badiger is independent board member.Here is the list of BDR Pharmaceuticals' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
yyqewhy | Team | - | Past | 5y 6m |
q{hbcgc | Team | - | Current | 2y 9m |
hswxypl | Team | - | Current | 3y 7m |
glvgnzi | Team | - | Past | 1y 9m |
upaidod | Team | - | Past | 4y 7m |
Independent board member | - | Current | 13y 10m | |
axnuedr | Independent board member | - | Past | 2y 2m |
wvfnmud | Independent board member | - | Past | 9y 3m |
xqqyvzy | Independent board member | - | Past | 9y 3m |
BDR Pharmaceuticals' employee count trend
BDR Pharmaceuticals has 1,006 employees as of Sep 26. Here is BDR Pharmaceuticals's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
BDR Pharmaceuticals's Competitors and alternates
Top competitors of BDR Pharmaceuticals include Bayer, Biological E and Wockhardt. Here is the list of Top 10 competitors of BDR Pharmaceuticals, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Manufacturer of drugs | - | 76/100 | ||
2nd | Biological E 1953, Hyderabad (India), Late Stage | Developer of vaccines for treating multiple diseases | $60M | 75/100 | |
3rd | Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients | - | 72/100 | ||
4th | Manufacturer of pharmaceutical products, including generics, biosimilars, and active pharmaceutical ingredients | $6.64M | 71/100 | ||
5th | Manufacturer of APIs, generic drugs, and formulation development services | - | 69/100 | ||
6th | Developer, manufacturer, and markets a broad range of pharmaceutical products | $50M | 68/100 | ||
7th | Amneal 2002, Bridgewater (United States), Public | Manufacturer of generics formulations | - | 68/100 | |
8th | Strides Pharma Science 1990, Bengaluru (India), Public | Manufacturer of generic pharmaceutical products and various specialty medical formulations | - | 68/100 | |
9th | Aurobindo Pharma 1986, Hyderabad (India), Public | Provider of generic biocatalytic products | - | 66/100 | |
10th | Orchid Pharma 1992, Chennai (India), Public | Company offering a suite of pharmaceutical solutions | - | 66/100 | |
38th | BDR Pharmaceuticals 2003, Mumbai (India), Late Stage | Developer and manufacturer of APIs as well as finished products | $94.9M | 56/100 |
Looking for more details on BDR Pharmaceuticals's competitors? Click here to see the top ones
Financials of BDR PharmaceuticalsFY 25 Available
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, the legal entity associated with BDR Pharmaceuticals, generated more than ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED has a compounded annual growth rate (CAGR) of 2% in the last 1 year.
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 3353 | 7065 | 2813 | 6467 | 3377 |
Total Sales | 8996 | 9213 | 4494 | 8762 | 5890 |
Total Expenses | 1497 | 9865 | 7732 | 4593 | 9280 |
Operating Expenses | 1569 | 8343 | 1868 | 4203 | 8911 |
Employee Expenses | 1290 | 6234 | 5879 | 6795 | 8501 |
Marketing Expenses | 9461 | 7993 | 3646 | 2145 | 6215 |
Operating Income (EBIT) | 9028 | 7910 | 4299 | 8107 | 4521 |
Interest Expenses | 8777 | 6959 | 7245 | 1941 | 3081 |
Expenses from other activities | 3379 | 4117 | 3437 | 4420 | 4160 |
Information Technology Expenses | 5680 | 1347 | 2143 | 1825 | 3984 |
EBITDA | 2527 | 8110 | 3810 | 5591 | 4351 |
Taxes | 8669 | 7698 | 2265 | 4076 | 9821 |
Net Profit | 6781 | 7916 | 8781 | 6173 | 7770 |
Balance Sheet | |||||
Assets | 5515 | 2098 | 2033 | 5901 | 7594 |
Cash Equivalent | 3428 | 2594 | 7273 | 3462 | 5283 |
Accounts Receivables | 3724 | 3035 | 9497 | 3015 | 5001 |
Inventory | 7614 | 3897 | 3501 | 2295 | 9441 |
Liabilities | 9011 | 4111 | 9427 | 6964 | 6073 |
Total Debt | 7131 | 8186 | 6899 | 9003 | 2472 |
Accounts Payable | 6929 | 6083 | 1682 | 5604 | 8035 |
Equities | 3587 | 5516 | 5152 | 9099 | 4075 |
Cashflow Statement | |||||
Cash from Operating activities | 6316 | 7591 | 2135 | 6881 | 8721 |
Cash from Investing activities | 1854 | 2266 | 2348 | 4357 | 8867 |
Net cash from Financing activities | 4011 | 9896 | 3290 | 4765 | 8664 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
BDR Pharmaceuticals's Investments and acquisitions
BDR Pharmaceuticals has made no investments or acquisitions yet.
Reports related to BDR Pharmaceuticals
Here is the latest report on BDR Pharmaceuticals's geography:
News related to BDR Pharmaceuticals
Media has covered BDR Pharmaceuticals for a total of 2 events in the last 1 year, 1 of them has been about company updates.
•
BDR Pharma Acquires Controlling Stake in Acme Formulation's Oral Solid BusinessVCCircle•Nov 10, 2026•BDR Pharmaceuticals
•
BDR Pharma Launches XATRONEM-AV to Combat Antimicrobial ResistanceIndiaMedToday•Jun 25, 2026•BDR Pharmaceuticals
•
CDSCO Panel Clears BDR Pharma's Abiraterone Oral Suspension, Seeks Phase IV TrialMedical Dialogues•Oct 15, 2025•BDR Pharmaceuticals
•
BDR Pharma Targets 2027 for IPO Launch, Seeks US AcquisitionsMoneycontrol•Apr 29, 2025•BDR Pharmaceuticals
•
BDR Pharmaceuticals launches BDENZA oral solution for prostate cancer treatmentIndiaMedToday•Jan 04, 2024•BDR Pharmaceuticals
•
BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution formIndiatimes•Jan 02, 2024•BDR Pharmaceuticals
•
Procaps Enters into Agreement with BDR Pharmaceuticals to Expand Oncology Portfolio in Latin AmericaFinance Colombia•Oct 18, 2023•Procaps Group, BDR Pharmaceuticals
•
BDR Pharma launches Zisavel capsules to treat invasive aspergillosis and mucormycosisIndiaMedToday•Oct 03, 2023•BDR Pharmaceuticals
•
Procaps Group and BDR sign agreement for oncology moleculesPharmaceutical Business Review•Sep 08, 2023•Procaps Group, BDR Pharmaceuticals
•
Are you a Founder ?
FAQs about BDR Pharmaceuticals
Explore our recently published companies
- Saalfo Tech - Mysuru based, 2016 founded, Unfunded company
- Tolia - Thane based, 1979 founded, Unfunded company
- Krishna's Herbal & Ayurveda - Jodhpur based, 2007 founded, Unfunded company
- Bregma Science - Bengaluru based, 2016 founded, Unfunded company
- http://nordible.co - Unfunded company
- Transformative Biotech - Boulder based, 2023 founded, Unfunded company